The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
The DOI matches its Crossref record; 250 of the 251 references it cites were found in a registry or an index.
Abstract
Newer generation antidepressant drugs (ADs) are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In this critical review, we evaluated the literature on adverse events, tolerability and safety of selective serotonin reuptake inhibitors, serotonin noradrenaline reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran and vortioxetine. Several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. They encompass gastrointestinal symptoms (nausea, diarrhea, gastric bleeding, dyspepsia), hepatotoxicity, weight gain and metabolic abnormalities, cardiovascular disturbances (heart rate, QT interval prolongation, hypertension, orthostatic hypotension), genitourinary symptoms (urinary retention, incontinence), sexual dysfunction, hyponatremia, osteoporosis and risk of fractures, bleeding, central nervous system disturbances (lowering of seizure threshold, extrapyramidal side effects, cognitive disturbances), sweating, sleep disturbances, affective disturbances (apathy, switches, paradoxical effects), ophthalmic manifestations (glaucoma, cataract) and hyperprolactinemia. At times, such adverse events may persist after drug discontinuation, yielding iatrogenic comorbidity. Other areas of concern involve suicidality, safety in overdose, discontinuation syndromes, risks during pregnancy and breast feeding, as well as risk of malignancies. Thus, the rational selection of ADs should consider the potential benefits and risks, likelihood of responsiveness to the treatment option and vulnerability to adverse events. The findings of this review should alert the physician to carefully review the appropriateness of AD prescription on an individual basis and to consider alternative treatments if available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Common side effects include nausea, vomiting, diarrhea, headache, insomnia, and agitation (104).”
From The 2023 Impact of Inflammatory Bowel Disease in Canada: Mental Health and Inflammatory Bowel Disease (2023) · cites this paper as [104]
In the citing paper
“Another drawback of long-term antidepressant treatment is concerned with the serious and bothersome side effects that may ensue with SSRI and SNRI, such as high rates of sexual dysfunction, bleeding (in particular gastrointestinal), weight gain, risk of fracture and osteoporosis, and hyponatremia.73”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [73]
In the citing paper
“Examples are switching from unipolar to bipolar course with antidepressant drugs [6,31] and supersensitivity psychosis, the onset of psychotic symptoms and co-occurring movement disorder with antipsychotic medications [4].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“For instance, several side effects of antidepressants are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
In the citing paper
“Since gastric symptomatology did not follow the somatic patterns typical of anxiety disturbances, venlafaxine was also suspected as a iatrogenic cause [6].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [6]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Barbui, C., Hotopf, M., Freemantle, N., Boynton, J., Churchill, R., Eccles, M., Geddes, Jr., Hardy, R., Lewis, G., & Mason, J. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002791 · Cited by 86
RetractedProjections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Suicide and suicidal behaviour
Turecki, G., & Brent, D. A. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00234-2 · Cited by 2,338
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Apathy and the Functional Anatomy of the Prefrontal Cortex–Basal Ganglia Circuits
Levy, R., & Dubois, B. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj043 · Cited by 1,285
Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940
Kessler, R. C. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.11.005 · Cited by 871
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Research works printed but not linked: 2
- 10.1345/aph.1A254 · doi:10.1345/aph.1a254 · Paper page
- 10.1210/endo.133.2.8344205 · doi:10.1210/endo.133.2.8344205 · Paper page
Cited by
Items 601–654 of 654
Lan, T., Wu, Y., Zhang, Y., Li, S., Zhu, Z., Wang, L., Mao, X., Li, Y., Fan, C., Wang, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19862742
Lan, T., Wu, Y., Zhang, Y., Li, S., Zhu, Z., Wang, L., Mao, X., Li, Y., Fan, C., Wang, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19862739
Brišnik, V., Vukas, J., Jung-Sievers, C., Lukaschek, K., Alexander, G. C., Thiem, U., Thürmann, P., Schüle, C., Fischer, S., Baum, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26719401
Brišnik, V., Vukas, J., Jung-Sievers, C., Lukaschek, K., Alexander, G. C., Thiem, U., Thürmann, P., Schüle, C., Fischer, S., Baum, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25807448
Brišnik, V., Rottenkolber, M., Vukas, J., Schechner, M., Lukaschek, K., Jung-Sievers, C., Gensichen, J., Thiem, U., Drey, M., Krüger, N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26981951
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590919
Lan, T., Wu, Y., Zhang, Y., Li, S., Zhu, Z., Wang, L., Mao, X., Li, Y., Fan, C., Wang, W., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19862736
Brišnik, V., Vukas, J., Jung-Sievers, C., Lukaschek, K., Alexander, G. C., Thiem, U., Thürmann, P., Schüle, C., Fischer, S., Baum, E., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26719404
Wilk, E. J., Howton, T. C., Fisher, J. L., Oza, V. H., Brownlee, R. T., McPherson, K. C., Cleary, H. L., Yoder, B. K., George, J. F., Mrug, M. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26590922
姚, 泗. (2025) · Medical Diagnosis · doi:10.12677/md.2025.156077
Li, X., Lu, M., Wang, X., Wu, D., Chen, Y., Ming, T., Gou, D., Yang, R., & Zhou, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1653929
Особенности терапевтического выбора антидепрессантов в кардиологической практике: обзор литературы
Golyshko, V. S., Балабанович, Т. И., & Savitski, I. S. (2025) · Кардиология в Беларуси · doi:10.34883/pi.2025.17.6.012
Wu, Y.-H., Tsai, S., Huang, S. R., & Hou, P. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1690792
Anti-Inflammatory Effect of Tea
Hu, S. (2026) · Springer eBooks · doi:10.1007/978-3-032-11828-8_10
The evolution of SSRI research: trajectories of knowledge domains across four decades
Westphal, L., Gräf, D. D., & Hallgreen, C. E. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07867-8
Kamel, E. M., Khadrawy, S. M., Yassin, N. Y. S., & Ahmed, N. A. (2026) · Journal of Applied Toxicology · doi:10.1002/jat.70099
Kang, B. S., Um, J., Hong, S., Park, H.-J., Park, J. H., Hwang, J., Kim, T., & Ko, H. S. (2026) · Diseases · doi:10.3390/diseases14020067
Zanao, T. A., Salvan, P., Razza, L. B., da Silva, P. H. R., Brunoni, A. R., & O’Shea, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-40364-2
Self-citationSeifert, J., Bleich, S., & Seifert, R. (2026) · Springer eBooks · doi:10.1007/978-3-662-72738-6_22
Wang, X., Xu, J., Li, M., Du, L., Wang, C., & Zhang, C. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c15325
Eltorki, Y. H., Abdallah, O., Alkudsi, Z., Elamin, W., Gharaibeh, A. M., Mustafa, M., Shameh, N. A., Riaz, S., Mahran, I., Al‐Khuzaei, N., et al. (2026) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s578820
Duncan, E., Hersant, H., & Khairova, R. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_4
Chappell, K. (2023) · theses.fr (ABES) · doi:10.70675/5afa484cz21e5z493azae47ze62ca3553104
Central neuromodulators in gastroenterology and gastropsychology. Focus on irritable bowel syndrome
Gubska, O., & Vanchytskiy, A. O. (2026) · GASTROENTEROLOGY · doi:10.22141/2308-2097.60.1.2026.717
Yu, Z., Wu, X., Yang, J., Pei, S., Wang, J., Cao, Z., Fang, J., & Shao, X. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1805907
Malan‐Müller, S., Contreras, F. P., Nto, N. J., Lowry, C. A., García-Valiente, A., Valles‐Colomer, M., Hemmings, S. M. J., Aidy, S. E., Lok, A., Mouhib, H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8279190/v1
Cai, C., Mei, Z., Yang, Y., Shi, Y., & Luo, S. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08036-7 · Cited by 1
Maß, R., Backhaus, K., Pütz, K., & Unkelbach, B. K. (2026) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2026.101077
Vaishnavi, V., Kumar, T. P., Valluru, R., Syamala, Y., Siva, C., & Bhavana, R. (2026) · SA pharmaceutical journal. · doi:10.36303/sapj.3549
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_16
Communication in the Depressed Brain
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_7
Chapter 15. Women: Pregnancy, Postpartum, and Breastfeeding
Kenkel, L., Astley, S., & Kang, L. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894551913.lg15
Self-reported antidepressant side effects in psychiatric patients with depressive disorders
von Knorring, J., Baryshnikov, I., Jylhä, P. J., Talaslahti, T., & Isometsä, E. T. (2026) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2026.2686197
A Pragmatic Algorithm for Selecting Psychopharmacology Treatment for Secondary Insomnia
Chen, A. C. N., Taj, F., Fonseka, L. N., & Osser, D. N. (2026) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002219
Su, J., Zhang, J. Z., Ding, Y., & Ying, Y. (2026) · Genes Brain & Behavior · doi:10.1111/gbb.70058
Management of Adverse Drug Effects for Adjunctive Analgesics
Lewis, S. J., Sjoquist, L. K., & Churchwell, M. D. (2026) · Springer eBooks · doi:10.1007/978-3-032-21675-5_19
Benneh, C. K., Abotsi, W. K. M., Moomin, A., Biney, R. P., Ofosu, J. O., Abeka, M. K., Tandoh, A., Adongo, D. W., & Woode, E. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05501-8
Dybka, E. J., Sokołowski, J., Czepczarz, A., Gryczko, J., Augustyniak, W. W., Cupiał, N. K., Mróz, T., Symon, Z., Pińczak, Z. K., & Gryczko, J. (2026) · African Journal of Biomedical Research · doi:10.69980/ajbr.v29i1s.9750
Wang, Y., Li, K., Yi, T., Chen, B., Li, Z., Chai, H., Hao, H., He, H., Du, X., Liu, S. S., et al. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112032
Nikam, P., Kadiri, S. K., & Kangralkar, V. A. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.579027
Gastrointestinal Diagnoses and Symptoms in Medicare Patients With Neuropsychiatric Diseases
Sonnenberg, A., Bakis, L. K., & Kohen, R. (2026) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002422
Earley, W. R., Durgam, S., Kozauer, S. G., Chen, C., Migliore, R., & Correll, C. U. (2026) · CNS Drugs · doi:10.1007/s40263-026-01314-8
Zhuang, J., Zhou, Y. K., Yu, G., Cheng, H., Chen, X., & Qian, R. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1845876
Kim, M. W., Oh, J., Jang, Y. K., Hwang, S., Choi, H., Park, R. W., Shin, J., Kim, J. H., & Lee, H. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e300
Psychopharmacological Mechanisms of Antidepressant Withdrawal: Insights From Venlafaxine
McClure, E. W. (2026) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70061
The analgesic effect and mechanism of celastrol in formalin-induced inflammatory pain mouse model
Wang, Y., Zhou, Q., Sun, Y., Xu, J., Ji, X., Wang, Y., & Lv, S. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05722-8
Tao, Y., Liu, S., Ren, Y., Xie, F., Sun, H., Bao, S., & Chen, Y. (2026) · Cambridge Prisms Global Mental Health · doi:10.1017/gmh.2026.10287
Schmidt, M. G., da Costa, J. S. D., Olinto, M. T. A., & Paniz, V. M. V. (2026) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232026319.05722024
Jismi, V. S., Ramakrishna, K. K., Mehta, U. M., Varambally, S. S., Shivakumar, V., Sathyaprabha, T. N., & Udupa, K. (2026) · Nutritional Psychiatry · doi:10.1016/j.nupsyc.2026.100041
Rescuing anxiety by targeting the neuronal-astrocytic iron signaling axis in male mice
Wang, Z., Yang, S., Tan, S., Huang, T., Yang, Q., Fu, J., Liu, Z., Li, B., Wu, Z., Min, J., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02921-z
Kinkulkina, M. A., Volel, B. A., Smolyarchuk, Е. А., En, M., Ivachtchenko, A. V., Ivashchenko, I. A., Ivanets, N. N., Avdeeva, T. I., Tikhonova, Y. G., Izyumina, T. A., et al. (2026) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2026-5-58-65
Alcalá, J. Á., Peña, M. J., & Roca, M. (2026) · Clinical Drug Investigation · doi:10.1007/s40261-026-01605-4
Acupuncture for depression-related insomnia: An overview of systematic reviews and meta-analyses
Li, Y., Li, Y., Chen, T., Tang, X., Xu, N., & Wu, Z. (2026) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2026.102788
Metadata
- Authors
- Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A.
- Affiliations
- The University of Texas Health Science Center at Houston (US)
- Universidade de São Paulo (BR)
- Centro de Investigación Biomédica en Red de Salud Mental (ES)
- University at Buffalo, State University of New York (US)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 85
- Issue
- 5
- Pages
- 270-288
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2477696699
- Semantic Scholar
- 4af046d5cf1f48ed09514ffef416d2de5c0d29cf
- Cited by
- 650
- References
- 251
- Citations by year
- 2026: 46 · 2025: 67 · 2024: 95 · 2023: 84 · 2022: 81 · 2021: 75 · 2020: 55 · 2019: 54 · 2018: 50 · 2017: 38 · 2016: 4
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- newer antidepressants, antidepressant side effects, drug safety, tolerability, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, bupropion, mirtazapine, trazodone, agomelatine, vilazodone, levomilnacipran, vortioxetine, gastrointestinal adverse effects, hepatotoxicity, weight gain, QT prolongation, sexual dysfunction, hyponatremia, osteoporosis, paradoxical effects, suicidality, antidepressant overdose, discontinuation syndrome, pregnancy and lactation, cancer risk, drug selection
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.